GROalpha human, >=97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, cell cultur

GROalpha human, >=97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, cell cultur

Stock Code: 3591256
Manufacturer Part No: G0657-10UG
Order Now for 7 day delivery
Click Add to Quote for price and delivery
Quantity: - +

Analysis Note

The biological activity is measured by its ability to induce chemotaxis of mouse BaF/3 cells transfected with hCXCR2.

Biochem/physiol Actions

GRO?, also called CXCL1 (chemokine (C-X-C motif) ligand 1), plays an essential role in neutrophil recruitment, and the initiation of angiogenesis. This gene is up-regulated in multiple cancer types such as, gastric cancer, renal cell carcinoma, prostate cancer and melanoma. The expression of this protein is also elevated in HER2 positive metastatic breast cancer. Its expression is increased in fibroblasts, which might be involved in breast tumor progression, and its stromal expression in breast cancer is linked to poor prognosis. This gene is also up-regulated in the aggressive phenotype of bladder cancer. Polymorphism rs4074 A in this gene is also associated with susceptibility to alcoholic cirrhosis.

General description

GRO?, also called CXCL1 (chemokine (C-X-C motif) ligand 1), is a member of the small soluble chemokine protein family. It belongs to the C-X-C subfamily, which is comprised of 17 members. It contains a conserved glutamic acid-leucine-arginine (ELR) domain. This protein is expressed on stromal cells such as, endothelial cells, fibroblasts and blood-circulating cells.

Physical form

Lyophilized from a 0.2 µm filtered solution in 25% acetonitrile and 0.1% trifluoroacetic acid containing 50 µg bovine serum albumin per 1 µg of cytokine.

ManufacturerSIGMA-ALDRICH
Impuritiesendotoxin, tested
Formlyophilized powder
Assay≥97% (SDS-PAGE)

There are no downloads for this product.